The Fight Has Moved to Banks and Feeds
The company that developed retatrutide is no longer waiting on federal regulators to shut down the market for copies of its unapproved obesity drug. It is going after the plumbing instead.
The company that developed retatrutide is no longer waiting on federal regulators to shut down the market for copies of its unapproved obesity drug. It is going after the plumbing instead.